Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 7(9): e2424, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24040434

RESUMO

BACKGROUND: Brucellosis, a zoonotic infection caused by one of the Gram-negative intracellular bacteria of the Brucella genus, is an ongoing public health problem in Perú. While most patients who receive standard antibiotic treatment recover, 5-40% suffer a brucellosis relapse. In this study, we examined the ex vivo immune cytokine profiles of recovered patients with a history of acute and relapsing brucellosis. METHODOLOGY/PRINCIPAL FINDINGS: Blood was taken from healthy control donors, patients with a history of acute brucellosis, or patients with a history of relapsing brucellosis. Peripheral blood mononuclear cells were isolated and remained in culture without stimulation or were stimulated with a panel of toll-like receptor agonists or heat-killed Brucella melitensis (HKBM) isolates. Innate immune cytokine gene expression and protein secretion were measured by quantitative real-time polymerase chain reaction and a multiplex bead-based immunoassay, respectively. Acute and relapse patients demonstrated consistently elevated cytokine gene expression and secretion levels compared to controls. Notably, these include: basal and stimulus-induced expression of GM-CSF, TNF-α, and IFN-γ in response to LPS and HKBM; basal secretion of IL-6, IL-8, and TNF-α; and HKBM or Rev1-induced secretion of IL-1ß, IL-2, GM-CSF, IFN-Υ, and TNF-α. Although acute and relapse patients were largely indistinguishable by their cytokine gene expression profiles, we identified a robust cytokine secretion signature that accurately discriminates acute from relapse patients. This signature consists of basal IL-6 secretion, IL-1ß, IL-2, and TNF-α secretion in response to LPS and HKBM, and IFN-γ secretion in response to HKBM. CONCLUSIONS/SIGNIFICANCE: This work demonstrates that informative cytokine variations in brucellosis patients can be detected using an ex vivo assay system and used to identify patients with differing infection histories. Targeted diagnosis of this signature may allow for better follow-up care of brucellosis patients through improved identification of patients at risk for relapse.


Assuntos
Brucella melitensis/imunologia , Brucelose/imunologia , Citocinas/biossíntese , Citocinas/metabolismo , Imunidade Inata , Leucócitos Mononucleares/imunologia , Adulto , Células Cultivadas , Meios de Cultura/química , Feminino , Perfilação da Expressão Gênica , Humanos , Imunoensaio , Técnicas In Vitro , Masculino , Pessoa de Meia-Idade , Peru , Reação em Cadeia da Polimerase em Tempo Real , Recidiva , Medição de Risco
2.
Methods Cell Biol ; 110: 81-109, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22482946

RESUMO

In cell signaling systems, the abundances of signaling molecules are generally thought to determine the response to stimulation. However, the kinetics of molecular processes, for example receptor trafficking and protein turnover, may also play an important role. Few studies have systematically examined this relationship between the resting state and stimulus-responsiveness. Fewer still have investigated the relative contribution of steady-state concentrations and reaction kinetics. Here we describe a mathematical framework for modeling the resting state of signaling systems. Among other things, this framework allows steady-state concentration measurements to be used in parameterizing kinetic models, and enables comprehensive characterization of the relationship between the resting state and the cellular response to stimulation.


Assuntos
Biologia Computacional/métodos , Retroalimentação Fisiológica , Modelos Biológicos , Algoritmos , Regulação da Expressão Gênica , Humanos , Cinética , Computação Matemática , Proteínas Proto-Oncogênicas c-mdm2/genética , Proteínas Proto-Oncogênicas c-mdm2/metabolismo , Transdução de Sinais , Proteína Supressora de Tumor p53/genética , Proteína Supressora de Tumor p53/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...